|
Re: Warrants at $2....
|
4
|
Resverlogix Corp.
|
Aug 07, 2018 01:45PM
|
|
New shares issued?
|
5
|
Zenith Epigenetics
|
Aug 07, 2018 08:36AM
|
|
Riding the Xtandi coat tails
|
9
|
Zenith Epigenetics
|
Jul 15, 2018 08:14PM
|
|
Re: TSX Buy -Ins...
|
3
|
Resverlogix Corp.
|
Jun 19, 2018 07:21PM
|
|
Re: Looking at the chart....
|
1
|
Resverlogix Corp.
|
Jun 18, 2018 08:03PM
|
|
A bit dated but still relevant article
|
6
|
Zenith Epigenetics
|
Jun 15, 2018 07:19PM
|
|
OncLive article mentioning ZEN-3694
|
5
|
Zenith Epigenetics
|
Jun 15, 2018 07:02PM
|
|
Forced buy ins
|
3
|
Resverlogix Corp.
|
Jun 13, 2018 03:19PM
|
|
Equity offering
|
5
|
Zenith Epigenetics
|
Jun 04, 2018 04:39PM
|
|
Re: Protecting shares from being borrowed by shorts
|
5
|
Resverlogix Corp.
|
May 18, 2018 12:11PM
|
|
Protecting shares from being borrowed by shorts
|
4
|
Resverlogix Corp.
|
May 18, 2018 11:37AM
|
|
Is CellCentric a competitor?
|
2
|
Zenith Epigenetics
|
May 15, 2018 06:27PM
|
|
Novartis' canakinumab (Ilaris)
|
4
|
Resverlogix Corp.
|
Mar 13, 2018 01:32PM
|
|
Re: Zenith and Breast Cancer
|
6
|
Zenith Epigenetics
|
Mar 11, 2018 02:36PM
|
|
Pfizer vs J&J - Nonmetastatic prostate cancer
|
1
|
Zenith Epigenetics
|
Feb 06, 2018 09:54AM
|
|
Awaken Dormant DNA, Epigenetically - Article in GEN
|
6
|
Zenith Epigenetics
|
Jan 12, 2018 06:03PM
|
|
Israel Patent Application
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 08:49AM
|
|
Beacon reiterates assessment
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 07:38PM
|
|
Re: Zenith AGM - Q&A
|
4
|
Zenith Epigenetics
|
Dec 19, 2017 01:09PM
|
|
Re: Competition from Constellation
|
3
|
Zenith Epigenetics
|
Dec 14, 2017 11:15AM
|
